We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Glucosamine Sulfate Aids Osteoarthritis Patients

By HospiMedica staff writers
Posted on 06 Feb 2001
A three-year, double-blind, placebo-controlled study of 212 patients suffering from knee osteoarthritis has demonstrated that 1,500 mg once a day of oral glucosamine sulfate can slow the progression of the disease and reduce pain and function limitations. More...
The multicenter study was published in the January 26 issue of The Lancet.

Disease progression was evaluated by measuring the joint space width on x-rays of the knee. Placebo patients experienced progressive joint space narrowing, representing further loss of cartilage, but patients who received glucosamine sulfate showed no further joint space narrowing. Additionally, pain and function limitation worsened with the placebo but improved with glucosamine sulfate. The study also showed that glucosamine sulfate is a safe compound.

The Lancet article warns against generalizing the study results to glucosamine products other than the one used in this study, which was Dona, manufactured by Rotta Pharmaceuticals, Inc. "Further studies may be necessary to see of administration of glucosamine sultate for even longer periods may reduce substantial disability after decades and/or the need for surgical joint replacement,” said Dr. Lucio Rovati, co-investigator from Milan, Italy.



Related Links:
The Lancet

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.